US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 14.820
  • +0.720+5.11%
Close Mar 28 16:00 ET
  • 14.850
  • +0.030+0.20%
Post 19:53 ET
4.14BMarket Cap-7841P/E (TTM)

Iovance Biotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
1.19M
482K
469K
238K
0
0
0
0
0
0
Operating revenue
--1.19M
--482K
--469K
--238K
--0
--0
--0
--0
--0
--0
Cost of revenue
10.76M
4.37M
4.34M
2.05M
0
0
0
0
Gross profit
-9.57M
-3.88M
-3.87M
-1.81M
0
0
0
0
Operating expense
13.07%450.99M
9.66%117.37M
14.04%114.49M
8.56%108.27M
20.87%110.86M
16.39%398.88M
7.61%107.04M
16.41%100.4M
22.48%99.73M
21.36%91.71M
Selling and administrative expenses
2.71%106.92M
13.00%29.9M
-3.33%26.96M
-16.72%21.93M
20.11%28.12M
24.42%104.1M
10.96%26.46M
33.54%27.89M
36.37%26.33M
19.33%23.41M
-General and administrative expense
----
----
----
----
20.11%28.12M
----
----
----
----
19.33%23.41M
Research and development costs
16.72%344.08M
8.56%87.47M
20.72%87.53M
17.63%86.35M
21.13%82.73M
13.80%294.78M
6.56%80.57M
10.94%72.5M
18.17%73.41M
22.08%68.3M
Operating profit
-15.46%-460.56M
-13.29%-121.26M
-17.90%-118.36M
-10.38%-110.09M
-20.87%-110.86M
-16.39%-398.88M
-7.61%-107.04M
-16.41%-100.4M
-22.48%-99.73M
-21.36%-91.71M
Net non-operating interest income expense
336.95%13.04M
81.60%3.12M
332.18%3.36M
700.26%3.08M
3,188.68%3.49M
561.86%2.99M
1,171.85%1.72M
547.50%777K
413.33%385K
-12.40%106K
Non-operating interest income
336.95%13.04M
81.60%3.12M
332.18%3.36M
700.26%3.08M
3,188.68%3.49M
561.86%2.99M
1,171.85%1.72M
547.50%777K
413.33%385K
-12.40%106K
Other net income (expense)
Income before tax
-13.04%-447.52M
-12.17%-118.14M
-15.44%-115M
-7.71%-107.01M
-17.21%-107.37M
-15.67%-395.89M
-6.03%-105.32M
-15.67%-99.62M
-22.12%-99.35M
-21.42%-91.61M
Income tax
-3.48M
-1.76M
-1.24M
-477K
0
0
0
0
Net income
-12.16%-444.04M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-15.67%-395.89M
-6.03%-105.32M
-15.67%-99.62M
-22.12%-99.35M
-21.42%-91.61M
Net income continuous Operations
-12.16%-444.04M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-15.67%-395.89M
-6.03%-105.32M
-15.67%-99.62M
-22.12%-99.35M
-21.42%-91.61M
Minority interest income
Net income attributable to the parent company
-12.16%-444.04M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-15.67%-395.89M
-6.03%-105.32M
-15.67%-99.62M
-22.12%-99.35M
-21.42%-91.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-12.16%-444.04M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-15.67%-395.89M
-6.03%-105.32M
-15.67%-99.62M
-22.12%-99.35M
-21.42%-91.61M
Basic earnings per share
24.10%-1.89
29.69%-0.45
26.98%-0.46
25.40%-0.47
13.79%-0.5
-11.66%-2.49
-1.59%-0.64
-14.55%-0.63
-18.87%-0.63
-13.73%-0.58
Diluted earnings per share
24.10%-1.89
29.69%-0.45
26.98%-0.46
25.40%-0.47
13.79%-0.5
-11.66%-2.49
-1.59%-0.64
-14.55%-0.63
-18.87%-0.63
-13.73%-0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 1.19M482K469K238K000000
Operating revenue --1.19M--482K--469K--238K--0--0--0--0--0--0
Cost of revenue 10.76M4.37M4.34M2.05M0000
Gross profit -9.57M-3.88M-3.87M-1.81M0000
Operating expense 13.07%450.99M9.66%117.37M14.04%114.49M8.56%108.27M20.87%110.86M16.39%398.88M7.61%107.04M16.41%100.4M22.48%99.73M21.36%91.71M
Selling and administrative expenses 2.71%106.92M13.00%29.9M-3.33%26.96M-16.72%21.93M20.11%28.12M24.42%104.1M10.96%26.46M33.54%27.89M36.37%26.33M19.33%23.41M
-General and administrative expense ----------------20.11%28.12M----------------19.33%23.41M
Research and development costs 16.72%344.08M8.56%87.47M20.72%87.53M17.63%86.35M21.13%82.73M13.80%294.78M6.56%80.57M10.94%72.5M18.17%73.41M22.08%68.3M
Operating profit -15.46%-460.56M-13.29%-121.26M-17.90%-118.36M-10.38%-110.09M-20.87%-110.86M-16.39%-398.88M-7.61%-107.04M-16.41%-100.4M-22.48%-99.73M-21.36%-91.71M
Net non-operating interest income expense 336.95%13.04M81.60%3.12M332.18%3.36M700.26%3.08M3,188.68%3.49M561.86%2.99M1,171.85%1.72M547.50%777K413.33%385K-12.40%106K
Non-operating interest income 336.95%13.04M81.60%3.12M332.18%3.36M700.26%3.08M3,188.68%3.49M561.86%2.99M1,171.85%1.72M547.50%777K413.33%385K-12.40%106K
Other net income (expense)
Income before tax -13.04%-447.52M-12.17%-118.14M-15.44%-115M-7.71%-107.01M-17.21%-107.37M-15.67%-395.89M-6.03%-105.32M-15.67%-99.62M-22.12%-99.35M-21.42%-91.61M
Income tax -3.48M-1.76M-1.24M-477K0000
Net income -12.16%-444.04M-10.50%-116.38M-14.20%-113.76M-7.23%-106.53M-17.21%-107.37M-15.67%-395.89M-6.03%-105.32M-15.67%-99.62M-22.12%-99.35M-21.42%-91.61M
Net income continuous Operations -12.16%-444.04M-10.50%-116.38M-14.20%-113.76M-7.23%-106.53M-17.21%-107.37M-15.67%-395.89M-6.03%-105.32M-15.67%-99.62M-22.12%-99.35M-21.42%-91.61M
Minority interest income
Net income attributable to the parent company -12.16%-444.04M-10.50%-116.38M-14.20%-113.76M-7.23%-106.53M-17.21%-107.37M-15.67%-395.89M-6.03%-105.32M-15.67%-99.62M-22.12%-99.35M-21.42%-91.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -12.16%-444.04M-10.50%-116.38M-14.20%-113.76M-7.23%-106.53M-17.21%-107.37M-15.67%-395.89M-6.03%-105.32M-15.67%-99.62M-22.12%-99.35M-21.42%-91.61M
Basic earnings per share 24.10%-1.8929.69%-0.4526.98%-0.4625.40%-0.4713.79%-0.5-11.66%-2.49-1.59%-0.64-14.55%-0.63-18.87%-0.63-13.73%-0.58
Diluted earnings per share 24.10%-1.8929.69%-0.4526.98%-0.4625.40%-0.4713.79%-0.5-11.66%-2.49-1.59%-0.64-14.55%-0.63-18.87%-0.63-13.73%-0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg